#NTAP
38.4% of #$NTAP volume traded off-exchange, vs a 34.9% average over the prior 4 sessions.
#$NTAP traded 0.8x its normal off-exchange volume on Nov 17, 5-day trend fading.
Off-exchange activity near its usual pace: no unusual block pressure this session.

Full story at the link.
NetApp (NTAP) Technical Levels: Support $168, Resistance $195
NTAP closed at $173.04: support $168.21, resistance $194.60; where the chart, options flow and dark pools stand after the close.
globaltradersacademy.com
November 18, 2026 at 2:41 PM
NetApp (NTAP) CEO George Kurian Sells $7.6M in Shares

NetApp CEO George Kurian has sold $7.6 million worth of company shares. The sale represents a significant transaction by the company's top executi…

https://newsstocks.live/news/netapp-ntap-ceo-george-kurian-sells-76m-in-shares #Finance #Markets
November 15, 2026 at 8:02 AM
🚨 $NTAP
CERNUDA CESAR (President) reported special transactions (Non-P/S).
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 17, 2026 at 10:07 PM
🚨 $NTAP
Kurian George (CEO) reported special transactions (Non-P/S).
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 17, 2026 at 10:08 PM
🚨 $NTAP
O'Callahan Elizabeth M (EVP, Chief Admin. Officer) reported special transactions (Non-P/S).
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 17, 2026 at 10:05 PM
🚨 $NTAP
De Lorenzo Daniel (SVP, Chief Accounting Officer) reported special transactions (Non-P/S).
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 17, 2026 at 10:06 PM
🚨 $NTAP
CERNUDA CESAR (President) sold 2,609 shares at an average price of $178.9000 per common share. (Date: 2026-11-16)
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 18, 2026 at 9:50 PM
#$NTAP traded 1.2x its normal off-exchange volume on Nov 16, 5-day trend fading.
34.5% of #$NTAP volume traded off-exchange, vs a 36.1% average over the prior 4 sessions.
Off-exchange activity near its usual pace: no unusual block pressure this session.

Full story at the link.
NetApp (NTAP) Technical Levels: Options Flow Mixed Between $168 and $196
NTAP at $177.85: support $168.21, resistance $196.44; the chart, options flow and dark pools are mixed.
globaltradersacademy.com
November 17, 2026 at 10:13 AM
#$NTAP off-exchange volume ran 0.9x normal on Nov 13, 5-day trend fading.
36.4% of #$NTAP volume traded off-exchange, vs a 39.3% average over the prior 4 sessions.
Off-exchange activity near its usual pace: no unusual block pressure this session.

Full story at the link.
NetApp (NTAP) Technical Levels: Options Flow, Dark Pools Line Up Below $196
NTAP at $176.48: support $168.21, resistance $196.37; the chart, options flow and dark pools line up bearish.
globaltradersacademy.com
November 16, 2026 at 8:33 PM
NetApp Director Deepak Ahuja Sells $684,185 in Shares

Deepak Ahuja, a director at NetApp (NTAP), sold shares worth $684,185. The transaction reflects a significant sale by a company insider. No furt…

https://newsstocks.live/news/netapp-director-deepak-ahuja-sells-684185-in-shares #Finance #Markets
November 15, 2026 at 8:02 AM
Options money in #$NTAP on Nov 13: $368K, 68% of it in calls.
Top trade: 382 Dec 18 calls, $1,910.
A 68/32 lean to calls: a tilt, not a one-sided bet.

Full story at the link.
#optionsflow #stocks #optionstrading #stockmarket
Week in Review: NetApp (NTAP) Options Flow and Dark Pools, Nov 9-13
Someone just made an outsized options bet on NTAP. GTA's flow data shows the strike, the timing, and why traders are watching for a move.
globaltradersacademy.com
November 16, 2026 at 6:03 AM
#$NTAP: Shares traded off the exchanges (% of volume): Nov 13 609,150 (36.4%).
Calls took $251K and puts $117K of the $368K in #$NTAP options premium (68% calls).

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Full story at the link.
#stocks #stockmarket
NTAP Technical Levels: Chart, Options Flow and Dark Pools Diverge at $181
NTAP at $181.37: support $168.21, resistance $197.92; the chart, options flow and dark pools point in different directions.
globaltradersacademy.com
November 14, 2026 at 6:55 AM
NetApp Raises Storage Prices, Keystone Rates By Up To 35 Percent

What actually changed, and why it matters for ONTAP customers.
November 18, 2026 at 10:15 AM
#$NTAP: Off-exchange trading by session (share of volume): Nov 12 523,694 (36.6%).
#$NTAP options tape: calls $1.8M, puts $191K (total $2.0M) (90% calls).

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Full story at the link.
#darkpool #stocks #stockmarket
NTAP Technical Levels: Chart, Options Flow and Dark Pools Diverge at $186
NTAP at $186.08: support $168.21, resistance $199.04; the chart, options flow and dark pools point in different directions.
globaltradersacademy.com
November 13, 2026 at 8:23 AM
NTAP — HOLD 🟡

NetApp, Inc. (NTAP) is rated HOLD as its software-led model remains highly profitable, but growth has slowed enough to make the valuation harder to stretch. The stock still screens rich versus hardware peers, so a reacceleration in revenue would likely be needed to just…

lf0.com ↗
November 11, 2026 at 7:40 PM
Lyrical Asset Management – Q3 2026 13F Update

• Total Portfolio Value: $7.4B (38 stocks)
• Biggest Add: $NXPI (+42% shares)
• Sold Out: $FFIV
• Largest Holding: $NTAP (7% of portfolio)

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#13F #Investing
Lyrical Asset Management: Q3 2026 13F portfolio changes
0 new positions, 3 sold out, 25 added to, 12 trimmed.
elixstocks.com
November 13, 2026 at 3:14 PM
Search for Cloud Technology Jobs and Careers with NetApp

What actually changed, and why it matters for ONTAP customers.
November 13, 2026 at 10:16 AM
NetApp Shares: Volume, Earnings and Technical Readings - Kalkine India

Revenue, margins, guidance — and what it says about AI-infrastructure demand.

Which line of the print do you read first — revenue mix or deferred revenue?
November 14, 2026 at 10:15 AM
Learn Why The Bull Case For NetApp (NTAP) Could Change Following Novus Adoption

The interesting part for storage admins is what it changes at the storage layer.

Which workload moved for you after this change, and which one did not?
November 13, 2026 at 6:15 PM
Renaissance – Q3 2026 13F Update

• Total Portfolio Value: $2.3B (232 stocks)
• New Position: $MU ($27M)
• Biggest Add: $NTAP (+7509% shares)
• Sold Out: $APO
• Largest Holding: $AAPL (2% of portfolio)

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#13F #Investing
Renaissance: Q3 2026 13F portfolio changes
24 new positions, 26 sold out, 58 added to, 141 trimmed.
elixstocks.com
November 12, 2026 at 6:27 PM
🚨 $NTAP
ELIZABETH O'CALLAHAN, a Officer, filed a notice of intent to sell 1,000 shares of common stock, valued at approximately $175,950.00, on 11/10/2026.
SEC Filing: NTAP
Click to view the official SEC document.
www.sec.gov
November 10, 2026 at 9:15 PM
$OMER - #NASDAQ - Omeros Corporation Advances YARTEMLEA Growth Amid Mixed Q3 Financials
Omeros Corporation Advances YARTEMLEA Growth Amid Mixed Q3 Financials
Omeros Corporation $omer continues to build momentum with its transplant therapy YARTEMLEA, which posted strong commercial results in Q3 2026. Gross sales reached $41.8 million, a 30% increase from the previous quarter, while net sales climbed 26% to $35.9 million. The therapy's adoption expanded notably, with 109 unique accounts ordering by the end of September—up 49% from June—and adult patients now representing about 70% of usage. Medicare's New Technology Add-on Payment (NTAP) program is providing significant reimbursement support, offering up to $287,000 per eligible inpatient case, and YARTEMLEA retains pass-through status through mid-2029, shielding it from upcoming Medicare reimbursement cuts. Despite these commercial gains, Omeros reported a GAAP net loss of $57.4 million for Q3, driven by various factors including noncash remeasurements, though adjusted non-GAAP results showed a modest net income of $4.7 million. The company ended the quarter with $95.3 million in cash and investments and generated positive operating cash flow. Looking ahead, Omeros expects discontinued operations income of $5 million to $6 million in Q4 and anticipates slightly higher operating expenses. CEO Gregory Demopulos highlighted ongoing efforts to strengthen the company’s financial position while scaling YARTEMLEA’s outpatient and educational programs. However, regulatory challenges remain, as the European CHMP issued a negative opinion on narsoplimab’s marketing authorization for TA-TMA treatment, and the compassionate use program for YARTEMLEA will be closed to new patients. Earlier this fall, Cantor Fitzgerald upgraded Omeros to Overweight, citing the impressive start of YARTEMLEA’s launch and raising peak sales estimates to $400 million based on anticipated U.S. market share. This bullish outlook contrasts with the stock’s current valuation, which analysts believe does not yet fully reflect YARTEMLEA’s potential. The company plans to provide more detailed guidance in 2027 as it continues to navigate growth and pipeline developments. U.S. markets are currently closed and will reopen tomorrow at 9:30 AM ET. Did you know? Stocks of companies with strong product launches often experience volatility as investors weigh early sales success against longer-term profitability and regulatory hurdles. Disclaimer This content is for entertainment and discussion purposes only. It is based on publicly available headlines and social media commentary, which can be messy and ever-evolving. We are not financial advisors, and this is not investment advice. The publisher may hold positions in securities mentioned. We aim to keep things accurate—if you catch something off, please let us know. Powered by - Trading Watch Premium This data is 100% free and is made possible by our Monthly Supporters.
dlvr.it
November 17, 2026 at 3:06 AM
There are 6 companies in the S&P 500 & NASDAQ 100 that flashed SMAC Sell Signals today: $AME, $EXE, $JCI, $NTAP, $NWSA, $ZBRA
November 11, 2026 at 4:02 AM
Medicare’s NTAP status for ZEVASKYN starts Oct. 1. It helps hospitals with the cost of treating Medicare patients. It is not a direct revenue boost for Abeona, and it does not mean Medicare covers 65% of the price.
November 10, 2026 at 10:55 AM